XML 31 R40.htm IDEA: XBRL DOCUMENT v3.2.0.727
Development, Commercialization and Supply Agreement - Additional Information (Detail) - USD ($)
$ in Thousands
6 Months Ended
Feb. 26, 2015
Jun. 30, 2015
License And Collaboration Agreements [Line Items]    
Licensing revenue   $ 375
Eddingpharm    
License And Collaboration Agreements [Line Items]    
Non-refundable up-front received $ 15,000  
Deferred revenue   $ 14,600
Licensing agreement term   16 years
Eddingpharm | Maximum    
License And Collaboration Agreements [Line Items]    
Additional upfront payment eligible to receive based on development, regulatory and sales Milestone $ 154,000  
Eddingpharm | Up-front Payment    
License And Collaboration Agreements [Line Items]    
Licensing revenue   $ 400